The Kingston General Hospital site is an acute-care teaching hospital affiliated with Queen's University located in Kingston, Ontario, Canada.

During the past decade, Respiratory Investigation Unit, Kingston General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Respiratory Investigation Unit, Kingston General Hospital" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Canadian Lung Association" with 1 trials as a collaborator and "Ontario Lung Association" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Respiratory Investigation Unit, Kingston General Hospital" are "COPD" (4 trials), "Chronic Obstructive Pulmonary Disease" (4 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Dyspnea" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Respiratory Investigation Unit, Kingston General Hospital" in a lesser frequency.

Most popular intervention types in "Respiratory Investigation Unit, Kingston General Hospital" are "Drug" (7 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nitric Oxide" (3 trials), "Placebo" (3 trials), "placebo" (2 trials), "ACL/FOR" (1 trials) and "Dead space breathing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Respiratory Investigation Unit, Kingston General Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Respiratory Investigation Unit, Kingston General Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Respiratory Investigation Unit, Kingston General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Respiratory Investigation Unit, Kingston General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".